US Supreme Court hears Teva arguments in Copaxone case


The highest court in the US will hear a dispute today (October 15) between pharmaceutical company Teva and generic rivals that are looking to market versions of its multiple sclerosis drug Copaxone (glatiramer acetate).

Teva, Sandoz, Mylan, Natco, US Supreme Court, patent, Copaxone

More on this story

US Supreme Court split on Teva case